The Latest Cardiac and Vascular News
KALAMAZOO, Mich., March 5, 2019 /PRNewswire/ — Innovative Cardiovascular Solutions, LLC (ICS), a privately held medical device company, today announced the first clinical use of its next-generation Emblok™ Embolic Protection System in patients undergoing transcatheter aortic valve replacement (TAVR) procedures in its European feasibility study. The cases were successfully performed by primary investigator […]
DUBLIN – March 4, 2019 – Medtronic plc (the “Company”) (NYSE:MDT) today announced the upsizing of the previously-announced cash tender offers by its wholly-owned subsidiaries, Medtronic, Inc. and Covidien International Finance S.A. (“CIFSA” and, together with Medtronic, Inc., the “Offerors”) for up to $1.9 billion combined aggregate purchase price (excluding accrued […]
March 4, 2019- Minnesota, United States and Melbourne, Australia – Osprey Medical (ASX: OSP) is pleased to announce the appointment of Mr Jim Surek as Vice President, Sales effective from March 1st. Mr Surek brings a wealth of experience and expertise to Osprey. He has over 25 years of senior […]
WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a private medical device company developing innovative venous stent solutions for peripheral vascular disease, today announced the appointment of Mark J. Garcia, MD, FSIR, FACR as its Chief Medical Officer. “Dr. Garcia has brought a wealth of clinical experience treating deep venous disease to our Board […]
KFAR-SABA, ISRAEL & ALISO VIEJO, Calif.–(BUSINESS WIRE)–CathWorks announced that Mike Feher has joined CathWorks as Vice President of Finance and Chief Financial Officer. His appointment coincides with US commercialization of the CathWorks FFRangio™ System. Mr. Feher will initially focus on the development of financial and operational capabilities, as well as creating […]
HINGHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) — Further expanding its global IP portfolio, Microbot Medical Inc. (Nasdaq CM: MBOT) received an official communication from the European Patent Office regarding its intention to grant European Patent Application No. 13 746 563, which covers an adjustable guidewire for use in percutaneous […]
ST. LOUIS, March 04, 2019 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2018 fourth quarter and full year ended December 31, 2018 on Tuesday, March 12, 2019 […]
SOUTH SAN FRANCISCO, Calif., March 04, 2019 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious cardiovascular diseases, today announced positive 12- and 24-week safety, efficacy and biomarker data for its investigational drug, mavacamten, from the company’s PIONEER […]
DANVILLE, Pa., March 4, 2019 /PRNewswire/ — The National Institutes of Health has awarded researchers at Geisinger $3.1 million over the next five years to explore innovative approaches for early, genomics-based detection of arrhythmogenic right ventricular cardiomyopathy (ARVC). ARVC is a degenerative heart disease responsible for approximately 20 percent of sudden cardiac death in individuals […]
EDEN PRAIRIE, Minn., March 01, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ: CHFS), today announced that effective February 25, 2019, the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals entering into employment with the Company. The equity awards […]
